Skip to search formSkip to main contentSkip to account menu

nebivolol

Known as: Nebivololum, Alpha,Alpha'-(Iminobis(Methylene))bis(6-Fluoro-3,4-dihydro)-2H-1-benzopyran-2-methanol, alpha,alpha'-(iminodimethylene)bis-(6-fluoro-2-chromanmethanol) 
A beta-1 adrenergic receptor antagonist with antihypertensive and vasodilatory activity. Nebivolol binds to and blocks the beta-1 adrenergic… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Heart failure (HF) in the elderly carries a poor prognosis. We used the SENIORS dataset of elderly HF patients aged ≥70 years in… 
Highly Cited
2006
Highly Cited
2006
Objectives To determine the effects of nebivolol on oxidative stress, insulin resistance, adiponectin and plasma soluble P… 
Highly Cited
2005
Highly Cited
2005
Background— Alterations in endothelial function may contribute to increased susceptibility of black Americans to cardiovascular… 
Highly Cited
2003
Highly Cited
2003
Abstract— To compare the effect of antihypertensive drugs on endothelium‐dependent vasodilation in the peripheral conduit… 
Highly Cited
2001
Highly Cited
2001
Background—Vascular endothelial dysfunction may predict future atherosclerosis. Hence, an antihypertensive agent that reverses… 
Highly Cited
2001
Highly Cited
2001
Racemic nebivolol, a beta-adrenergic blocker showing very promising beta-adrenergic antagonist properties in comparison to other… 
Highly Cited
1994
Highly Cited
1994
1. Nebivolol, a selective beta 1-adrenoceptor antagonist with antihypertensive effects, has haemodynamic effects suggestive of a… 
Highly Cited
1991
Highly Cited
1991
Nebivolol is a new β1-antagonist that acutely reduces arterial blood pressure without depressing cardiac function. The present…